We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Gilead Sciences Inc on Tuesday announced a strategic collaboration with Genesis Therapeutics Inc to discover and deve ...
Gilead Sciences Inc on Thursday said that the marketing authorisation in Japan for its chimeric antigen receptor T-ce ...
The following is a round-up of updates by global companies, issued on Tuesday and not separately reported by Alliance ...
The World Health Organization said Friday it "strongly recommended" Pfizer Inc's covid-19 antiviral pill Paxlovid for ...
GlaxoSmithKline PLC on Wednesday said majority-owned investee ViiV Healthcare has agreed to settle a global patent in ...
Gilead Sciences Inc on Friday said that the US Food & Drug Administration granted its Veklury drug expedited approval ...
Gilead Sciences Inc and Merck & Co Inc announced Tuesday the start of a Phase 2 clinical study evaluating an investig ...
Gilead Sciences Inc on Tuesday said it has entered into a clinical collaboration with Vir Biotechnology Inc focused o ...
Gilead Sciences Inc on Monday said it has increased its product sales guidance for 2020 as one of its drugs used to t ...
Kite, a Gilead Sciences Inc portfolio company, on Wednesday said it and Oxford BioTherapeutics Ltd have entered into ...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 3.78 | 4.23102753526 | 89.34 | 93.1 | 85.37 | 7324 | 90.56296876 | DE |
4 | 3.82 | 4.27771556551 | 89.3 | 93.1 | 85.37 | 4550 | 89.42842038 | DE |
12 | 5.72 | 6.54462242563 | 87.4 | 93.1 | 81.28 | 5763 | 88.55921233 | DE |
26 | 21.380001 | 29.8020648146 | 71.739999 | 93.1 | 66.27 | 4848 | 82.19583299 | DE |
52 | 20.24 | 27.7716794731 | 72.88 | 93.1 | 57.18 | 5016 | 73.06450201 | DE |
156 | 31.87 | 52.0326530612 | 61.25 | 93.1 | 52.06 | 4357 | 71.81363728 | DE |
260 | 34.73 | 59.4793629046 | 58.39 | 93.1 | 46.165 | 10697 | 65.71414213 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions